Phio Pharmaceuticals
PHIO
PHIO
15 hedge funds and large institutions have $1.82M invested in Phio Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
12% less funds holding
Funds holding: 17 → 15 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Holders
15
Holding in Top 10
–
Calls
$447K
Puts
$359K
Top Buyers
| 1 | +$218K | |
| 2 | +$185K | |
| 3 | +$58.1K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$38.2K |
| 5 |
VF
Virtu Financial
New York
|
+$35.5K |
Top Sellers
| 1 | -$54K | |
| 2 | -$43K | |
| 3 | -$39K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$21.3K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$19.2K |